E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/18/2008 in the Prospect News PIPE Daily.

New Issue: Lpath concludes $6.4 million tranche of $12 million stock sale

By Devika Patel

Knoxville, Tenn., Aug. 18 - Lpath, Inc. completed a $6.4 million tranche of a $12 million private placement of stock on Aug. 15, according to an 8-K filed Monday with the Securities and Exchange Commission.

The company sold class A common shares at $0.95 per share. Investors also received warrants for 25% of the number of shares bought. The warrants are exercisable at $1.25.

San Diego-based Lpath develops therapeutic treatments for human diseases.

Issuer:Lpath, Inc.
Issue:Class A common shares
Amount:$12 million
Price:$0.95
Warrants:25% coverage
Warrant strike price:$1.25
Settlement date:Aug. 15 (for $6.4 million)
Stock symbol:OTCBB: LPTN
Stock price:$1.35 at close Aug. 15

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.